Cancer Research Powered by iPSC Market Insights, Therapeutic Advances, and Future Potential

According to Persistence Market Research, the global induced pluripotent stem cells market size is likely to be valued at US$ 2,051.9 Mn in 2025 and is expected to reach US$ 3,360.0 Mn by 2032, growing at a CAGR of 7.3% during the forecast period from 2025 to 2032.

Growing investment in fundamental research, particularly by academic institutions and research organizations, has greatly enhanced the understanding of molecular pathways involved in disease development. In recent years, studies on induced pluripotent stem cells (iPSCs) have provided deeper insights into gene regulation, improving knowledge of disease mechanisms, diagnostic potential, and therapeutic strategies. iPSCs share a gene expression profile with embryonic stem cells (ESCs), retaining both pluripotency and self-renewal capabilities, making them invaluable for regenerative medicine and drug discovery.